Theravance Biopharma Stock Volume Indicators Chaikin AD Line
| TBPH Stock | USD 9.47 0.14 1.46% |
| Symbol |
Indicator |
The output start index for this execution was zero with a total number of output elements of sixty-one. The Accumulation/Distribution line was developed by Marc Chaikin. It is interpreted by looking at a divergence in the direction of the indicator relative to Theravance Biopharma price. If the Accumulation/Distribution Line is trending upward it indicates that the price may follow. If the Accumulation/Distribution Line becomes flat while Theravance Biopharma price is still rising (or falling) then it signals a flattening of the price values.
Theravance Biopharma Technical Analysis Modules
Most technical analysis of Theravance Biopharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Theravance from various momentum indicators to cycle indicators. When you analyze Theravance charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Theravance Biopharma Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Theravance Biopharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Theravance Biopharma based on widely used predictive technical indicators. In general, we focus on analyzing Theravance Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Theravance Biopharma's daily price indicators and compare them against related drivers, such as volume indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Theravance Biopharma's intrinsic value. In addition to deriving basic predictive indicators for Theravance Biopharma, we also check how macroeconomic factors affect Theravance Biopharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2021 | 2022 | 2023 (projected) | Payables Turnover | 2.35 | 4.24 | 26.65 | Days Of Inventory On Hand | 513.23 | 83.81 | 9.0E-6 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Theravance Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Theravance Biopharma's short interest history, or implied volatility extrapolated from Theravance Biopharma options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Entertainment Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Warren Buffett Holdings Invested over 60 shares | |
 | Hedge Favorites Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | SRI Sustainable Growth Invested few shares | |
 | Momentum Invested few shares | |
 | Driverless Cars Invested over 50 shares | |
 | Manufacturing Invested over 30 shares | |
 | Macroaxis Picks Invested over 30 shares | |
 | Investor Favorites Invested over 60 shares | |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theravance Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Theravance Stock please use our How to Invest in Theravance Biopharma guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Theravance Biopharma. If investors know Theravance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Theravance Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.03) | Revenue Per Share 1.293 | Quarterly Revenue Growth 0.075 | Return On Assets (0.06) | Return On Equity (0.23) |
The market value of Theravance Biopharma is measured differently than its book value, which is the value of Theravance that is recorded on the company's balance sheet. Investors also form their own opinion of Theravance Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Theravance Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Theravance Biopharma's market value can be influenced by many factors that don't directly affect Theravance Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Theravance Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Theravance Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Theravance Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.